Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

V.H.J. van der Velden, A. Sluijs-Geling, B.E.S. Gibson, J.G.T. Marvelde, P.G. Hoogeveen, W.C.J. Hop, K. Wheatley, M.B. Bierings, G.J. Schuurhuis, S.S.N. de Graaf, E.R. van Wering, J.J.M. van Dongen

Research output: Contribution to journalArticleAcademicpeer-review

127 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1599-1606
Issue number9
Publication statusPublished - 2010

Cite this